Bio-Pharma Post-Logistics: The Evolution of Saudi Arabia’s Cold Chain — How We Handle the Next Generation of Sensitive Biotech Imports
Introduction: A Kingdom at the Crossroads of Biotech and Logistics Saudi Arabia is no longer simply a market that receives pharmaceutical products. It has become a destination for some of the most complex, temperature-sensitive, and time-critical biologics ever manufactured — from mRNA-based therapies and gene-editing compounds to cell and gene…






